Neurosciences
ROCHESTER, Minn. — An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising option for preventing relapses in[...]
Latest stories
Discovery Science
October 8, 2025
Research
October 6, 2025
Cancer
October 2, 2025
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community